New Delhi, March 1 (IANS) The developer of Covid-19 vaccine Covaxin, Bharat Biotech is considering an initial public offering that could raise over $500 million, according to sources cited by multiple reports.Discussions are underway including key aspects of the proposed share sale, including size and timing, they said.Bharat Biotech plans Rs 200–250 crore of capital expenditure in FY26 for a large vaccine manufacturing facility being developed under Sapigen Biologix Pvt Ltd in Bhubaneswar, Od…
Trending
- Lo Naveena Review: Humour, Heartbreak, and Friendship Shine in This Charming Kannada Entertainer
- Sattendru Maarudhu Vaanilai Review: Jai and Meenakshi Govindarajan Deliver a Wildly Entertaining Tamil Thriller You Cannot Miss
- Shikhandi (2026) Review: A Riveting Paranormal Thriller That Awakens Ancient Legends
- Sherr (2026) Movie Review: A Raw Kannada Crime Drama That Packs a Punch
- Mr. Work From Home Review: Trigun’s Bold Leap From Silicon Valley to Soil Strikes a Meaningful Chord
- Harudu (2026) Review: Venkat’s Gritty Cop Drama Delivers Raw Action and Solid Entertainment
- Kartavya Review: Saif Ali Khan Delivers a Gripping Performance in This Bold Caste-Crime Thriller on Netflix
- Karuppu Review: Suriya’s God Mode Delivers a Rousing Mass Entertainer That Hits Where It Matters Most